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Abstract
Background: To identify high risk patients without cardiovascular disease requires assessment of
risk factors. Primary care providers must therefore determine which patients without
cardiovascular disease should be highest priority for cardiovascular risk assessment. One approach
is to prioritise patients for assessment using a prior estimate of their cardiovascular risk. This prior
estimate of cardiovascular risk is derived from risk factor data that are routinely held in electronic
medical records, with unknown blood pressure and cholesterol levels replaced by default values
derived from national survey data. This paper analyses the test characteristics of using such a
strategy for identification of high risk patients.
Methods:  Prior estimates of Framingham cardiovascular risk were derived in a population
obtained from the Health Survey for England 2003. Receiver operating characteristics curves were
constructed for using a prior estimate of cardiovascular risk to identify patients at greater than 20%
ten-year cardiovascular risk. This was compared to strategies using age, or diabetic and
antihypertensive treatment status to identify high risk patients.
Results: The area under the curve for a prior estimate of cardiovascular risk calculated using
minimum data (0.933, 95% CI: 0.925 to 0.941) is significantly greater than for a selection strategy
based on age (0.892, 95% CI: 0.882 to 0.902), or diabetic and hypertensive status (0.608, 95% CI:
0.584 to 0.632).
Conclusion:  Using routine data held on primary care databases it is possible to identify a
population at high risk of cardiovascular disease. Information technology to help primary care
prioritise patients for cardiovascular disease prevention may improve the efficiency of
cardiovascular risk assessment.
Background
Because they are at high risk of cardiovascular events,
patients with cardiovascular disease are the highest prior-
ity for preventive interventions. Some patients without
cardiovascular disease are also at high risk and are the next
priority for prevention. In patients without cardiovascular
disease, the Framingham cardiovascular equation is
widely used to determine probability of a cardiovascular
event [1]. UK guidelines recommend treatment at a ten-
year Framingham cardiovascular (CVD) risk of 20% [2].
Calculating Framingham cardiovascular risk requires
knowledge of a patient's age, sex, diabetic status, smoking
status, total cholesterol, HDL cholesterol and whether or
not they have existing cardiovascular disease. Risk factor
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assessment requires patient time, staff time and laboratory
tests. Furthermore, not all patients assessed are eligible for
treatment. To make best use of resources for identification
of patients eligible for preventive treatments it would be
helpful to pre-select and prioritise for assessment those
patients most likely to benefit from treatment. How could
we do this before a patient's risk factors are known? In
health systems where patients have electronic medical
records it is possible to calculate all patients' cardiovascu-
lar risks before they attend for cardiovascular risk assess-
ment. This is done using all the cardiovascular risk factors
that are already recorded in the electronic medical records
(such as age, sex and diabetic status) and using prior esti-
mates of (default) cardiovascular risk factor values for risk
factor values that are unknown. Calculating a prior esti-
mate of cardiovascular risk allows primary care providers
to prioritise assessment of patients whose cardiovascular
risks are highest and who are therefore most likely to be
eligible for and benefit from assessment.
The cost effectiveness of a preventive strategy using this
approach has previously been described [3] and the
approach has been recommended in the recent draft NICE
guidelines for lipid lowering [4]. To facilitate this strategy,
software has been produced by iSoft [iSOFT, Daventry
Road, Banbury, Oxfordshire, OX16 3JT.] and MSDi
[MSDi, Hertford Road, Hoddesdon, Hertfordshire, EN11
9BU.] to calculate prior estimates of cardiovascular risk.
However, to date details of the method for calculating
prior estimates of cardiovascular risk have not been pub-
lished.
This paper describes how default risk factor values may be
obtained and used to calculate prior estimates of cardio-
vascular risk. Since diagnostic algorithms work well in the
populations from which they are derived, they should be
validated in a different data set. The paper validates the
prior estimates of cardiovascular risk by using them to cat-
egorise patients in a separate population as high-risk.
Methods
Electronic medical records include age, sex and generally
include accurate information on antihypertensive drug
treatment status and diabetic status. However for some
patients no additional risk factor information may be
available. In order to calculate cardiovascular risk, default
risk factor values therefore may need to be provided for
smoking status, total cholesterol, HDL cholesterol and
blood pressure. Default risk factor values are the most
likely values for the patient.
At all ages and in both sexes, non-smokers, non-diabetics,
those without cardiovascular disease and those not on
antihypertensive treatment outnumber smokers, diabet-
ics, those with cardiovascular disease and those on antihy-
pertensive treatment. For each of these risk factors
therefore the default is that the risk factor is absent.
For continuous variables (total cholesterol, HDL choles-
terol, systolic blood pressure), default risk factor values
were derived from the Health Survey for England of 1998
[5]. This was done as follows. The survey population was
divided into eight age bands (16–24, 35–34, 35,44,
45–54, 55–64, 65–74, 75–84 and 85+) and two gender
groups (male and female). These sixteen groups were sub-
divided into those taking and not taking antihypertensive
treatment; those with and without cardiovascular disease;
those with and without diabetes; smokers and non-smok-
ers. This made a total of 256 categories. For each of these
categories, average cholesterol level, average high-density
lipoprotein cholesterol (HDL) level, average systolic
blood pressure and average diastolic blood pressure were
calculated.
Some categories (e.g. males, 16–24, on antihypertensive
treatment, with cardiovascular disease, with diabetes and
smokers) are very uncommon. Because of this it is not
possible to calculate a stable average for these categories.
Where the Health Survey for England 1998 contained
fewer than 10 individuals in a category, smokers were
merged with non-smokers. If the category still contains
fewer than 10 individuals, diabetics were merged with
non-diabetics. If the category still contains fewer than 10
individuals, those with and without cardiovascular dis-
ease were merged. If the category still contains fewer than
10 individuals, those taking and not taking antihyperten-
sive treatment were merged. In this way a list of default
blood pressures was calculated for every possible age, sex
and risk factor category. The values are available on-line
[6].
The diagnostic value of CVD risk estimates derived using
default risk factor values was investigated by testing the
model in the Health Survey for England of 2003 [5].
Because the Framingham risk equation was derived from
individuals aged 30 to 74 without cardiovascular disease,
the population used for validation was all patients in this
age group without cardiovascular disease. Patients on
antihypertensive treatment and patients with diabetes
were included in the validation population. There are
18,553 individuals in the Health Survey for England
2003: 10,741 are aged 30 to 74, of these 4,954 of these
have sufficient cardiovascular risk factor information
recorded to calculate CVD risk. This 4,954 includes 120
individuals who have cardiovascular disease. Excluding
them leaves 4,834 individuals aged 30 to 74, free from
cardiovascular disease but with sufficient risk factors to
calculate CVD risk.BMC Public Health 2008, 8:25 http://www.biomedcentral.com/1471-2458/8/25
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In England, a population of 12,500 would be expected to
include about this number of individuals aged 30 to 74
without cardiovascular disease. This is roughly equivalent
to the population cared for by a large group practice. The
risk factor data were entered into SPSS and ten-year cardi-
ovascular risks were each calculated for each individual –
their "true" cardiovascular risk.
The reference standard for cardiovascular risk assessment
is full clinical risk factor assessment. This means assess-
ment of all cardiovascular risk factors, using the mean of
blood pressures taken at two clinic visits and a single
measure of total cholesterol and HDL cholesterol. Varia-
tion in measured risk factors can have a significant impact
on the identification of patients as eligible for treatment,
it is therefore important to incorporate this effect into the
model [7-10]. In order to model this, a "clinically deter-
mined" cardiovascular risk was calculated for each indi-
vidual, based on the mean of two clinically measured
blood pressures and cholesterol levels [1]. This was added
to the dataset. Clinically measured blood pressure incor-
porates the effects of chance (biological) variation on
blood pressure and cholesterol measurement. Two meas-
ured blood pressures were generated for each individual
in the population using a previously described methodol-
ogy [7-9]. This method adjusts true blood pressure (the
survey blood pressure) by an error term. [Measured BP =
True BP × (1 + Error term)]. A series of normally distrib-
uted error terms are generated in Excel as random num-
bers with a mean of zero and a standard deviation equal
to the coefficient of variation of between-visit, measured
blood pressure. This between-visit coefficient of variation
is derived from meta-analysis [11]. Two clinically meas-
ured cholesterol levels were also generated for each indi-
vidual. Measured cholesterol levels incorporate an error
term based on the coefficient of variation derived from
published studies: 7.2% for total cholesterol and 7.5% for
HDL cholesterol [12]. In effect, the clinically determined
cardiovascular risk is an estimate of the true cardiovascu-
lar risk.
Electronic medical records almost always contain accurate
data on age, gender, antihypertensive drug treatment sta-
tus and diabetic status. If electronic medical records are
available these are the minimum data that are available
for estimation of cardiovascular risk. A "minimum data"
estimate of cardiovascular risk was calculated using these
data, with default risk factor values for missing informa-
tion. Each patient was assigned to one the 256 risk factor
categories and assigned default risk factor values appropri-
ate to that category.
Electronic medical records often contain smoking status
and an estimate of blood pressure. A "semi-complete
data" estimate of cardiovascular risk was calculated with
smoking status a single blood pressure in addition to min-
imum data.
There are other methods of prioritising patients for cardi-
ovascular risk assessment. One approach is to prioritise
diabetics and hypertensive patients (those already on anti-
hypertensive treatment). This was recommended in the
National Service Framework for Coronary Heart Disease
[13]. Under such a strategy, hypertensive diabetics are the
highest priority, followed by diabetics and hypertensive
patients. Another approach is to prioritise patients by age,
assessing the oldest first. For comparison, strategies prior-
itising patients using these methods are also assessed. The
five modelled strategies are outlined in Table 1.
Receiver operating characteristic (ROC) curves illustrate
the ability of a diagnostic test to discriminate, in this case
between "true" ten-year cardiovascular risk greater and
less than 20%. They plot the relationship between sensi-
tivity and one minus specificity at a range of cut off test
values. Taking true cardiovascular risk as the reference
standard, ROC curves were constructed in SPSS 14.0 for
"clinically estimated", semi-complete data" and "mini-
mum data" risk estimates, for a prioritising diabetic and
hypertensive patients and for a strategy prioritising by age.
ROC curves are summarised by the area under the curve
(C-statistic).
Table 1: Descriptions of the ten-year cardiovascular risks and prioritisation strategies used in this paper
Label for strategy Risk factors Strategy
Clinical CVD risk Age, sex, diabetic status, antihypertensive treatment status, smoking 
status. Clinically estimated blood pressure (mean of two measurements), 
total cholesterol, and HDL cholesterol.
Highest risk first
Semi-complete data Age, sex, diabetic status, antihypertensive treatment status, smoking status 
and clinically estimated blood pressure (one measurement)
Highest risk first
Minimum data Age, sex, diabetic status, antihypertensive treatment status. Highest risk first
NSF-CHD Diabetic status, antihypertensive treatment status Hypertensive diabetics, then diabetics, 
hypertensives & others
Age Age Oldest firstBMC Public Health 2008, 8:25 http://www.biomedcentral.com/1471-2458/8/25
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For each of the strategies the sensitivity and specificity of
assessing the highest priority decile of the population
aged 30 to 74 was calculated. This is intended to illustrate
the effects of implementing patient identification strate-
gies informed by prioritisation of patients at high risk of
CVD in primary care.
Results
Seven hundred and fifty (15.5%) of the 4,834 patients are
at greater than 20% ten-year cardiovascular risk. The ROC
curves are shown in Figure 1.
Area under the curve is significantly greater for a strategy
assessing patients in descending order of age (C-statistic
0.892, 95% CI: 0.882 to 0.902) than for a strategy priori-
tising diabetics and hypertensives (C-statistic 0.608, 95%
CI: 0.584 to 0.632). A strategy prioritising patients for
assessment by a prior estimate of cardiovascular risk based
on minimum data (age, sex, diabetic and antihypertensive
treatment status) has a significantly greater area under the
curve (C-statistic 0.933, 95% CI: 0.925 to 0.941) than one
prioritising by age. A strategy prioritising patients for
assessment by a prior estimate of cardiovascular risk based
on semi-complete data (age, sex, diabetic, antihyperten-
sive treatment status, smoking status and a single blood
pressure) has a significantly greater area under the curve
(C-statistic 0.976, 95% CI: 0.972 to 0.980) than one pri-
oritising by age. (Table 2)
Using semi-complete data to select 10% of persons aged
30 to 74 for CVD risk factor assessment has a sensitivity of
0.589, a specificity of 0.929 and a positive predictive value
of 0.915. In other words, a practice following such a strat-
egy can identify 58.9% of high-risk patients by assessing
only one tenth of persons aged 30 to 74. Furthermore,
91.5% of those assessed will be at high risk. Using mini-
mum data to select 10% of persons for assessment has a
sensitivity of 0.511, a specificity of 0.915 and a positive
predictive value of 0.754. Using only age to select 10% of
persons for assessment has a sensitivity of 0.425, a specif-
icity of 0.900 and a positive predictive value of 0.624.
Using the National Service Framework strategy to select
10% of persons for assessment has a sensitivity of 0.253,
a specificity of 0.871 and a positive predictive value of
0.393.
Discussion
The principal problem with ROC curves is that they may
be based on biased populations. However a population
drawn from the Health Survey for England is unlikely to
be biased. A second problem is that the analysis is carried
out on a large population. This may make clinically trivial
differences between the receiver operating characteristics
of different strategies statistically significant. There are
only small differences between using prior risk estimation
in a practice with only age, sex, diabetic status and antihy-
pertensive drug treatment status on all patients and one
that also has smoking status and a blood pressure on all
patients. Nevertheless it is clear that the strategies priori-
tising patients by any prior estimate of cardiovascular risk
Table 2: Areas under the curve for different methods of identifying patients at greater than 20% ten-year cardiovascular risk from a 
population of 4651 adults aged 30 to 74
Strategy Area under the curve Standard Error Asymptotic 95% Confidence Interval
Clinical CVD risk 0.993 0.001 (0.991 – 0.996)
Semi-complete data 0.976 0.002 (0.972 – 0.980)
Minimum data 0.933 0.004 (0.925 – 0.941)
NSF-CHD 0.608 0.012 (0.584 – 0.632)
Age 0.892 0.005 (0.882 – 0.902)
Receiver operating characteristic curve of the ability of an  estimate of cardiovascular risk to diagnose a true ten-year  cardiovascular risk of over 20% Figure 1
Receiver operating characteristic curve of the ability 
of an estimate of cardiovascular risk to diagnose a 
true ten-year cardiovascular risk of over 20%. The 
areas under the curves are shown in Table 2.
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are a significant improvement on using age, or diabetic
and hypertensive status.
This paper demonstrates that a prior estimate of cardio-
vascular risk based on data commonly held in electronic
medical records has valuable characteristics as a screening
test for high risk of cardiovascular disease. This is not to
suggest that it is a substitute for cardiovascular risk assess-
ment, rather that it is useful for prioritising patients for
such an assessment. A cardiovascular assessment strategy
based on a prior estimate of cardiovascular risk is clearly
superior to prioritising diabetics and hypertensives or pri-
oritising by age. Using such an approach, it is possible to
identify a population of whom the majority are at high
risk of cardiovascular disease. This population comprises
the great majority of high-risk patients. Using information
technology to calculate prior estimates of risk and rank
patients by their estimated risk would greatly facilitate
such a strategy. Such developments are now in place.
Information technology can either provide electronic
prompts to remind primary care physicians to assess
patients opportunistically when they consult or can be
used to produce lists of patients for active invitation and
assessment.
In primary care, some patients have complete risk factor
information while others have some information missing:
most often, cholesterol levels [14]. The most efficient way
to make use of this information is therefore to use
recorded risk factor information when it is available and
default values when it is not.
The test characteristics of the selection strategy depend on
the number of patients identified for assessment. As more
patients are identified for assessment a greater proportion
of these identified patients are not high-risk at > 20% ten-
year CVD risk. However, any selection strategy has a
higher specificity than unselected assessment.
This paper describes pre-selection using prior estimates of
cardiovascular risk using the Framingham cardiovascular
risk equation in an English population. Other cardiovas-
cular risk equations have been derived from different orig-
inal data sources in continental Europe [15], Scotland
[16] and the UK [17]. It is possible that future guidelines
may adopt a different cardiovascular risk equation to
determine eligibility for treatment. Calculating prior esti-
mates of cardiovascular risk is not dependent on any sin-
gle risk equation, it requires only that some of the
principal determinants of cardiovascular risk are known
and that default risk factor values can be obtained for the
population to whom the equation is to be applied. It
would be of interest to determine the receiver operating
characteristics of different equations in different popula-
tions. The main determinants of cardiovascular risk (age,
sex, smoking status, diabetic status, blood pressure, cho-
lesterol levels) are the same in all risk equations. There is
therefore no reason to believe that the findings would be
fundamentally different in other populations.
Conclusion
When identifying patients for primary prevention of car-
diovascular disease, selecting patients for cardiovascular
risk assessment using a prior estimate of cardiovascular
risk is clearly a more efficient strategy than selecting based
on other criteria. Software to assist in this process has the
potential to improve the identification of patients at high
risk of cardiovascular disease.
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Appendix
What this paper adds
When blood pressure and cholesterol levels are unknown
it is possible to use routine survey data to calculate a prior
estimate of cardiovascular risk.
Using even the minimum of data available to primary care
teams in their electronic medical records databases it
therefore is possible to predict cardiovascular risk.
This risk prediction is sufficiently accurate to prioritise
patients for cardiovascular disease assessment.
Policy Implications
More use could be made of routine data that are held in
electronic medical records databases in primary care.
Information technology should be developed to make
convert this database information into useful knowledge
to guide cardiovascular prevention. Primary care teams
should be encouraged to make use of such knowledge.
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